Palisade Bio (PALI) Change in Accured Expenses (2010 - 2026)

Palisade Bio (PALI) has 17 years of Change in Accured Expenses data on file, last reported at $2.6 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $2.6 million, up 524.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 4038.95% YoY), and the FY2025 annual result was $576000.0, up 1128.57% from the prior year.
• Change in Accured Expenses advanced to $2.6 million in Q1 2026 per PALI's latest filing, from $677000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $2.6 million in Q1 2026 and troughed at -$1.3 million in Q3 2025.
• A 5-year average of $175823.5 and a median of $100000.0 in 2023 frame the typical range for Change in Accured Expenses.
• On a YoY basis, Change in Accured Expenses climbed as much as 2318.67% in 2025 and fell as far as 914.29% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$307000.0 in 2022, then slumped by 74.27% to -$535000.0 in 2023, then soared by 151.03% to $273000.0 in 2024, then surged by 147.99% to $677000.0 in 2025, then jumped by 278.43% to $2.6 million in 2026.
• Business Quant data shows PALI's Change in Accured Expenses at $2.6 million in Q1 2026, $677000.0 in Q4 2025, and -$1.3 million in Q3 2025.